3 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported): April 8, 2005
IN VERITAS MEDICAL DIAGNOSTICS, INC.
------------------------------------
(Exact name of registrant as specified in charter)
Colorado 000-49972 84-15719760
---------------------------- ----------- -------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
The Green House, Beechwood Business Park, North, Inverness, Scotland IV2 3BL
----------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
In Vivo Medical Diagnostics, Inc.
------------------------------------------------------------
(Former Name or former address, if changed since last report
Registrant's telephone number, including area code: 011-44-1463-667347
------------------
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instructions A.2. below):
/_/ Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
/_/ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
/_/ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
/_/ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item 5.03. Amendments to Certificate of Incorporation or Bylaws; Change in
Fiscal Year
Effective April 8, 2005, the Company (i) changed its name from In Vivo
Medical Diagnostics, Inc. to In Veritas Medical Diagnostics, Inc. and (ii)
increased its authorized common stock from 100,000,000 shares of common stock,
$.001 par value and 500,000,000 shares of common stock, $.001 par value.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IN VERITAS MEDICAL DIAGNOSTICS, INC.
Date: April 14, 2005 /s/ John Fuller
------------------------------------
John Fuller
Chief Executive Officer